Prevalence, awareness, and control of hypertension in Greece before and after the COVID-19 pandemic: May Measurement Month survey 2019–2022

The COVID-19 pandemic had an adverse impact on several cardiovascular risk factors. This study investigated the prevalence, awareness and treatment of hypertension in Greece before and after the pandemic. Data were collected in the context of the May Measurement Month (MMM) global survey initiated b...

Full description

Saved in:
Bibliographic Details
Published in:Hellenic journal of cardiology 2024-05
Main Authors: Menti, Ariadni, Kollias, Anastasios, Papadakis, John A., Kalaitzidis, Rigas G., Milionis, Haralampos, Krokidis, Xenophon, Nikitas, George, Maragkoudakis, Spyridon, Makaris, Emmanouil, Papachristou, Evangelos, Sarakis, Vasilios, Lanaras, Leonidas, Gkaliagkousi, Eugenia, Goumenos, Dimitrios, Grassos, Charalampos, Kallistratos, Manolis S., Katsi, Vasiliki, Konstantinidis, Dimitrios, Kotsis, Vasileios, Kyriakoulis, Konstantinos G., Makris, Thomas, Manios, Efstathios, Manolis, Athanasios, Marketou, Maria, Papadopoulos, Dimitrios, Pikilidou, Maria I., Protogerou, Athanasios, Sarafidis, Pantelis, Theodorakopoulou, Marieta, Tsioufis, Konstantinos, Zebekakis, Pantelis, Doumas, Michael, Stergiou, George S.
Format: Article
Language:English
Subjects:
Blood pressure
COVID-19
Epidemiology
Hypertension
Prevalence
Screening
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The COVID-19 pandemic had an adverse impact on several cardiovascular risk factors. This study investigated the prevalence, awareness and treatment of hypertension in Greece before and after the pandemic. Data were collected in the context of the May Measurement Month (MMM) global survey initiated by the International Society of Hypertension. Adult volunteers (age ≥ 18 years) were recruited through opportunistic screening in public areas across cities in Greece in 2019 and 2022. Medical history and triplicate sitting blood pressure (BP) measurements were taken using validated automated upper-arm cuff devices. The data were uploaded to the international MMM cloud platform. Hypertension was defined as systolic BP ≥ 140 mm Hg and/or diastolic ≥90 mm Hg and/or self-reported use of drugs for hypertension. The same threshold was used to define uncontrolled BP in treated individuals. Data from 12,080 adults were collected (5,727/6,353 in MMM 2019/2022; men 46/49%, p 
ISSN:1109-9666
2241-5955
2241-5955
DOI:10.1016/j.hjc.2024.05.017